Sellas Life Sciences Group Inc (NASDAQ: SLS) is having a rough day in the market today, trading on losses of more than 18% early on. Interestingly enough, there is no clear catalyst for the downward movement. Nonetheless, it may be setting the stage for a very strong play. Here’s what’s going on:
SLS Stock Dips: Now Is The Time To Buy
After seeing a dramatic rise in value a couple of sessions ago, profit taking started to hit and Sellas Life Sciences stock is continuing down today. Nonetheless, now may be the perfect time to get involved.
In a press release issued this morning, SLS announced a catalyst that will be coming in just a week. The company will be hosting a research and development investor event a week from today.
The event will be a KOL Symposium for investors and will be held Friday, November 15, 2019 from 8:15 a.m. to 10:00 a.m. in New York.
In the release, the comapny said that the KOL Symposium will include an overview of its ongoing clinical development programs for galinpepimut-S (GPS). In particular, SLS will focus on its Phase 3 trial of GPS in AML, a trial that is expected to be initiated in the fourth quarter of 2019.
The event will also feture leaders involved in development, including Hagop M. Kantarjian, M.D. Chair of the Department of Leukemia and Associate Vice President for Global Academic Programs at the University of Texas MD Anderson Cancer Center, Javier Pinilla-Ibarz, M.D., Ph.D., Senior Member of the Malignant Hematology & Immunology Program and Director for Immunotherapy for Malignant Hematology at the H. Lee Moffitt Cancer Center and others.
Why Now Is The Time To Buy
With declines making headlines, many investors are feeling fear. However, now is likely the perfect time to buy. Here’s why:
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Click below to continue reading.